Acknowledgement
This research was supported by the Basic Science Research Program through the National Re-search Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2016R1A6A1A03012845, and NRF- 2020R1A2B5B02001733), Republic of Korea.
References
- K. S. Park, X. Sun, M. E. Aikins, and J. J. Moon, Non-viral COVID-19 vaccine delivery systems, Adv. Drug Deliv. Rev., 169, 137-151 (2021). https://doi.org/10.1016/j.addr.2020.12.008
- N. Pardi, M. J. Hogan, F. W. Porter, and D. Weissman, mRNA Vaccines-a new era in vaccinology, Nat. Rev. Drug Discov., 17, 261-279 (2018). https://doi.org/10.1038/nrd.2017.243
- N. N. Zhang, X. F. Li, Y. Q. Deng, H. Zhao, Y. J. Huang, G. Yang, and C. F. Qin, A thermostable mRNA vaccine against COVID-19, Cell, 182, 1271-1283. e1216 (2020). https://doi.org/10.1016/j.cell.2020.07.024
- M. A. Liu, A comparison of plasmid DNA and mRNA as vaccine technologies, Vaccines, 7, 37 (2019). https://doi.org/10.3390/vaccines7020037
- H. H. Nguyen, J. Park, S. J. Park, C. S. Lee, S. Hwang, Y. B. Shin, T. H. Ha, and M. Kim, Long-term stability and integrity of plasmid-based DNA data storage, Polymers, 10, 28 (2018). https://doi.org/10.3390/polym10010028
- P. Roy and R. Noad, Virus-like particles as a vaccine delivery system: Myths and facts, Hum. Vaccin., 4, 5-12 (2008). https://doi.org/10.4161/hv.4.1.5559
- Z. Y. Yang, L. S. Wyatt, W. P. Kong, Z. Moodie, B. Moss, and G. J. Nabel, Overcoming immunity to a viral vaccine by DNA priming before vector boosting., J. Virol., 77, 799-803 (2003). https://doi.org/10.1128/JVI.77.1.799-803.2003
- K. Wylon, S. Dolle, and M. Worm, Polyethylene glycol as a cause of anaphylaxis, Allergy Asthma Clin. Immunol., 12, 1-3 (2016). https://doi.org/10.1186/s13223-015-0107-8
- S. Uzgun, G. Nica, C. Pfeifer, M. Bosinco, K. Michaelis, J.-F. Lutz, M. Schneider, J. Rosenecker, and C. Rudolph, PEGylation improves nanoparticle formation and transfection efficiency of messenger RNA, Pharm. Res., 28, 2223-2232 (2011). https://doi.org/10.1007/s11095-011-0464-z
- R. Webster, V. Elliott, B. K. Park, D. Walker, M. Hankin, and P. Taupin, PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals, In F. M. Veronese (eds.). PEGylated protein drugs: Basic science and clinical applications, 127-146 (2009).
- S. A. Smith, L. I. Selby, A. P. Johnston, and G. K. Such, The endosomal escape of nanoparticles: toward more efficient cellular delivery, Bioconjugate Chem., 30, 263-272 (2018). https://doi.org/10.1021/acs.bioconjchem.8b00732
- O. Boussif, F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P, Behr, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine, Proc. Nat. Acad. Sci., 92, 7297-7301 (1995). https://doi.org/10.1073/pnas.92.16.7297
- Y. Yang, Y. Jia, Y. Xiao, Y. Hao, L. Zhang, X. Chen, J. He, Y. Zhao, Z. Qian, Tumor-Targeting Anti-MicroRNA-155 Delivery Based on Biodegradable Poly (ester amine) and Hyaluronic Acid Shielding for Lung Cancer Therapy, ChemPhysChem, 19, 2058-2069 (2018). https://doi.org/10.1002/cphc.201701375
- R. V. Benjaminsen, M. A. Mattebjerg, J. R. Henriksen, S. M. Moghimi, and T. L. Andresen, The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH, Mol. Ther., 21, 149-157 (2013). https://doi.org/10.1038/mt.2012.185
- J. Chen, H. Tian, A. Kano, A. Maruyama, X. Chen, and T. G. Park, In vitro and in vivo gene delivery using polyethyleniminepoly (hydroxyethyl glutamine) as a non-viral carrier, J. Control. Release, 152, e134-e136 (2011). https://doi.org/10.1016/j.jconrel.2011.08.045
- R. Racine and Mummert, M. E. Hyaluronan endocytosis: mechanisms of uptake and biological functions, Brian Ceresa (eds.). Molecular Regulation of Endocytosis, 377-390 (2012).
- A. Akinc, M. Thomas, A. M. Klibanov, R. Langer, Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis, J. Gene Med., 7, 657-663 (2005). https://doi.org/10.1002/jgm.696